Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Evenamide by Newron Pharmaceuticals for Schizophrenia: Likelihood of Approval
Evenamide is under clinical development by Newron Pharmaceuticals and currently in Phase III for Schizophrenia. According to GlobalData, Phase III...